| abstract |
The invention provides methods and compositions for using immunostimulatory nucleic acids to treat non-allergic inflammatory diseases. Non-allergic inflammatory diseases that may be treated according to the methods and products of the invention include psoriasis and inflammatory bowel disease. The invention further provides methods for augmenting a Th 1 response to immunostimulatory nucleic acid involving inhibition of prostaglandin-mediated counter-regulatory response. |